In this study of NSCLC patients treated with ICI monotherapy or ICIs CC, we found that LIPI status was significantly associated with PFS and OS in the ICI monotherapy group, but not in the ICIs CC group. This evidence concerns the gene LIPI and non-small cell lung carcinoma.